All sectoral indices in the red, PSU Bank dips 2%
Natco Pharma shares rallied as much as 6.4 percent after the Mekaguda facility received zero observations from the US health regulator.
"....announce successful completion of regulatory inspection from the United States Food and Drug Administration (USFDA) for its active Trade Support pharmaceutical ingredient (API) facility in Mekaguda Village, Hyderabad," the pharma company said in its filing.
The inspection by USFDA was conducted during the period February 12-16, 2018.
